Skip to main content
. 2010 Mar 1;12(5):516–520. doi: 10.1093/eurjhf/hfq026

Table 2.

Body composition, resting energy expenditure, exercise tolerance, hormones, appetite, and caloric intake in the cross-sectional cohort

Group Control (n = 7) HF cross-sectional (n = 12) HTx cross-sectional (n = 12) P-value
All Control vs. HF Control vs. HTx HF vs. HTx
BMI (kg/m2) 27.8 ± 4.2 23.1 ± 3.1 31.5 ± 5.5 <0.001 0.03 0.08 <0.001
Total mass (kg) 87 ± 15 69 ± 6 92 ± 15 <0.001 <0.004 >0.2 <0.001
Fat mass (kg)a 24 ± 9 17 ± 2 31 ± 9 <0.006 <0.13 0.10 <0.002
Lean mass (kg)a 66 ± 8 55 ± 4 61 ± 11 0.12 0.04 >0.2 0.17
Fat % 26 ± 7 23 ± 2 33 ± 7 <0.009 >0.2 <0.03 <0.004
Abdominal fat mass (kg) 11.7 ± 5 8.4 ± 2 16.8 ± 6 <0.01 >0.2 <0.06 <0.004
Abdominal fat % 27 ± 8 23 ± 4 33 ± 7 <0.009 >0.2 0.05 <0.003
Waist circumference (cm) 99 ± 10 86 ± 4 111 ± 13 <0.001 <0.10 <0.05 <0.001
REE (kcal/day) 1710 ± 384 1812 ± 352 2036 ± 528 >0.2 >0.2 <0.13 >0.2
REE (kcal/m2/h) 35 ± 5 41 ± 9 41 ± 10 >0.2 <0.14 <0.15 >0.2
Peak VO2 (mL/kg/min)a 27 ± 9 11 ± 2 15 ± 3 <0.001 <0.001 <0.001 0.18
Glucose (mg/dL) 86.4 ± 5.8 105.4 ± 16.8 96.4 ± 16.1 <0.05 <0.02 0.17 <0.19
Insulin (µU/mL) 11.6 ± 7.1 21.8 ± 10.9 18.1 ± 6.9 0.08 <0.03 0.14 >0.2
HOMA (mMmU/L2)b 2.5 ± 1.6 5.7 ± 3.0 4.3 ± 1.9 <0.04 0.01 0.12 0.20
Leptin (ng/mL)c 8.56 ± 5.2 8.14 ± 7.6 16.65 ± 11.6 <0.06 >0.2 0.07 <0.03
Leptin per fat % (ng/mL/%)a 0.27 ± 0.1 0.29 ± 0.1 0.48 ± 0.3 <0.10 >0.2 0.06 <0.10
Hunger fasting (0–10) 5.8 ± 2.5 5.0 ± 2.4 3.4 ± 1.3 <0.05 >0.2 0.02 0.07
Breakfast (kcal) 907 ± 260 832 ± 364 1238 ± 421 0.03 >0.2 <0.07 0.01
Hunger after breakfast (0–10) 1.1 ± 1.5 2.0 ± 2.0 1.9 ± 2.8 >0.2 >0.2 >0.2 >0.2
Leptin AUC (mg min/mL) 2.54 ± 1.4 2.73 ± 2.5 5.41 ± 3.7 0.05 >0.2 <0.05 0.03
Hunger before lunch (0–10) 7.3 ± 1.6 6.6 ± 2.8 6.1 ± 2.7 >0.2 >0.2 >0.2 >0.2
Lunch (kcal) 1185 ± 650 391 ± 103 831 ± 309 <0.008 <0.002 0.13 0.06

Bold denotes statistical significance (P < 0.05). BMI, body mass index; HTx, heart transplantation.

aPeak VO2 and DEXA scans were not performed in the seven HF patients on inotropic therapy and thus leptin per fat % was not available.

bHOMA was not measured in patients with diabetes (n = 3 HF and n = 2 HTx); upper limit of normal for HOMA is 2.5 mMmU/L2.5

cNormal range leptin for this assay: men, 3.8 ± 1.8; women, 7.4 ± 3.7 ng/mL (Phoenix Pharmaceuticals).